|
2024 TUBERCULOSIS CONFERENCE
The Union – North America Region
and the
National Tuberculosis Coalition of America
| |
|
April 16-19, 2024
Baltimore, MD
| |
Call for Poster Abstracts | |
|
Abstract Content
- Abstracts may be written in English, French, or Spanish; however, we encourage posters to be in English.
- Abstracts must be a maximum of 300 words*, excluding title, headings, and authors’ names and affiliations
- (*Please note: this is a change for 2024 - previously, NTCA accepted abstracts of 350 words and NAR requested 250 words.)
- The body of the abstract should contain the following sections (Note: section names should be included in the abstract, and written in all CAPITAL LETTERS):
- TITLE
- AUTHORS (last names and initials only, omit degrees), institutions, city, country (omit street address and zip/postal code); underline the name of presenting author
- BACKGROUND
- DESIGN/METHODS or INTERVENTION/RESPONSE
- RESULTS (Give both numbers and proportions where applicable)
- CONCLUSION
| Abstracts that do not adhere to the required format and word limit will be excluded from consideration. | |
Abstracts may involve scientific research or public health practice, in the following categories: | |
Category 1: Scientific research
This category includes clinical, programmatic translational, and operational research.
It is recommended that the abstracts in Category 1 be organized using the following sections:
-
Background: State study objectives, study questions, or a description of the challenge addressed by the research.
-
Design/Methods: State the setting, methods, desired outcomes, procedures, and techniques used to collect and analyze information. Include a description of participants, procedures, measures, and appropriate statistical analyses.
-
Results: Present specific findings to date.
-
Conclusion: State the implications of the results and key recommendations. Present specific findings on how the research addressed the study, question, or challenge. Highlight opportunities for future research as well as implications for further research for TB prevention and care programs.
| |
Category 2: Public health practice/education and training
This category includes, but is not limited to, the following: TB clinical care, including new treatment regimens, TB epidemiology and surveillance, TB nurse case management, LTBI reporting and surveillance, TB outcomes of program initiatives, TB diagnostic and laboratory updates, Contact investigations and large outbreak reporting, use of eDOT and other technologies to deliver care, health equity/disparities, and programmatic responses to newcomers to North America.
It is recommended that the abstracts in Category 2 be organized using the following sections (if an abstract cannot address these sections, it is not eligible for submission).
-
Background: What is the reason for implementation? What is the problem being addressed? Identify the context and the specific challenges to program implementation. Describe the activity, program, or policy for which the issue was addressed. Describe target populations, geographic sites/locations, and scale and type of activity or service.
-
Intervention/Response: How was the challenge overcome? Detail the methods, activities and implementation steps used to overcome the challenge. Describe the methods, procedures and techniques used to collect and analyze information that informed your conclusions. Identify the course of action used to address program implementation issues.
-
Results: What are the lessons learned? Describe the results and impact of the project. Explain the potential application or benefit to other programs. Describe what worked and what did not work and theevidence that led to this determination.
-
Conclusions: State the implications of the effective public health practice and key recommendations. Highlight opportunities for future program practice, as well as implications for other programs or settings.
| |
|
Scoring Criteria
Note: The 2024 TB Conference Abstract Committee has elected to embrace The Union (IUATLD) scoring criteria. The scoring rubric can be found here.
Relevance (Weight 1.0) -- 0-5 points
Methods/Intervention or Response (Weight 1.0) -- 0-5 points
Results/Impact (Weight 1.0) -- 0-5 points
Clarity of the Message (Weight 0.5) -- 0-5 points
Originality (Weight 0.5) -- 0-5 points
Total: 20 points
| |
|
Top Scoring Abstract Award
This award will be given to the abstract with the highest score based on the scoring system and submitted by a student, trainee, fellow, or a junior professional (with < 5 years of professional experience in TB Care and Prevention). This includes nurses, physicians, public health professionals, epidemiologists, researchers, etc.
Submission
We are developing an online portal for submission of the 2024 TB Conference poster abstracts. We anticipate that the portal will be open by early November.
| |
Deadline for Submission: November 28, 2023 | |
|
Notification
- We will notify the submitting author of acceptance for oral (if selected) or poster presentation or rejection no later than December 20, 2023.
- Abstracts may be accepted immediately, or conditionally. If accepted conditionally, we will contact you with instructions for revisions needed, or to provide assistance. If you may need assistance, we encourage you to submit your abstract early (at least 2 weeks before the deadline) and request assistance.
- All accepted abstracts will be published in the meeting proceedings.
-
Please note: If the abstract is accepted for oral presentation, authors will be required to submit presentations for review by February 29, 2024. Oral presentations will be limited to 7 minutes in length, with 3 minutes for discussion. Presenters of abstracts selected for oral presentation must also sign a conflict-of-interest disclosure form. This form will be provided to the authors and must be submitted along with the presentation.
| |
|
In addition to the opportunity to submit poster abstracts, the 2024 TB Conference will also include opportunities to present/discuss challenging clinical cases and challenging programmatic issues facing TB programs with a panel of TB experts.
Information about these additional opportunities will be shared soon.
| |
For Additional Information | |
See what's happening on our social sites | | | | |
